Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 2543059, 7 pages
https://doi.org/10.1155/2017/2543059
Research Article

CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population

1Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241001, China
2Department of Urology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241001, China
3Department of Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241001, China
4Department of Urology, North Hospital, CHU of Saint-Etienne, 42055 Saint-Etienne, France

Correspondence should be addressed to Chun Pu; moc.361@upnuhcrp

Received 14 January 2017; Revised 27 March 2017; Accepted 23 April 2017; Published 24 May 2017

Academic Editor: Tilman Todenhöfer

Copyright © 2017 Gang Feng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Bai, L. Wang, D. Wang et al., “Clinicopathologica epidemiological characteristics and change tendencies of renal cell carcinoma in Shanxi Province of China from 2005 to 2014,” PLos One, vol. 10, no. 12, article e0144246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Feng, F. Jiang, C. Pan, C. Pu, H. Huang, and G. Li, “Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma,” Urologic Oncology, vol. 32, no. 1, p. 44.e9-14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Li, G. Feng, A. Gentil-Perret, C. Genin, and J. Tostain, “Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer,” The Journal of Urology, vol. 180, no. 2, pp. 510–513, 2008, discussion 513-4. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Tu, C. Zhang, H. Yan et al., “CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development,” Cell Research, vol. 25, no. 3, pp. 275–287, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Zhang, J. Zhang, Z. Wang et al., “CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancer,” Oncology Letters, vol. 5, no. 4, pp. 1189–1194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Jiang, J. Zhuang, H. Duan et al., “CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis,” Blood, vol. 120, no. 11, pp. 2330–2339, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Feng, F. Fang, C. Liu, F. Zhang, H. Huang, and C. Pu, “CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy,” International Urology and Nephrology, vol. 44, no. 6, pp. 1663–1669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. N. Klimosch, A. Försti, J. Eckert et al., “Functional TLR5 genetic variants affect human colorectal cancer survival,” Cancer Research, vol. 73, no. 24, pp. 7232–7242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Lam, O. Shvarts, J. W. Said et al., “Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma,” Cancer, vol. 103, no. 12, pp. 2517–2525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Wu, Y. S. Kwon, M. Labib, D. J. Foran, and E. A. Singer, “Magnetic resonance imaging as a biomarker for renal cell carcinoma,” Disease Markers, vol. 2015, no. 3, Article ID 648495, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Cai, L. Sun, L. Cui et al., “A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma,” Urologia Internationalis, vol. 91, no. 2, pp. 206–212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Du, T. Su, X. Tan et al., “Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma,” Gene, vol. 512, no. 1, pp. 64–69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. de Martino, A. Haitel, G. Schatzl, H. C. Klingler, and T. Klatte, “The CASP8-652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis,” The Journal of Urology, vol. 190, no. 2, pp. 717–722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Tan, Y. Wang, Y. Han et al., “Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression,” British Journal of Cancer, vol. 109, no. 12, pp. 3105–3115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Partyka, K. Tupikowski, A. Kolodziej et al., “Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population,” Urologic Oncology, vol. 34, no. 9, p. 419.e13-9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Kleinrath, C. Gassner, P. Lackner, M. Thurnher, and R. Ramoner, “Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma,” Journal of Clinical Oncology, vol. 25, no. 7, pp. 845–851, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Ma, L. W. Li, and J. L. Cheng, “Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients,” Oncology Letters, vol. 9, no. 2, pp. 651–656, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Diekstra, J. J. Swen, E. Boven et al., “CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma,” European Urology, vol. 68, no. 4, pp. 621–629, 2015. View at Publisher · View at Google Scholar · View at Scopus